Claes Wahlestedt
University of Miami
H-index: 105
North America-United States
Top articles of Claes Wahlestedt
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Natural antisense transcripts as versatile regulators of gene expression | Andreas Werner Aditi Kanhere Claes Wahlestedt John S Mattick | 2024/4/17 | |
The interaction of radiotherapy and dual inhibition of BET and HAT/p300 in colorectal cancer. | Michael Matthew Pennock Sanjay Pandey Claes Wahlestedt Chandan Guha Chaoyuan Kuang | 2024/1/20 | |
Dysregulation of the Histone Demethylase KDM6B in Alcohol Dependence is Associated with Epigenetic Regulation of Inflammatory Signaling Pathways | Addiction biology | Andrea L Johnstone Nadja S Andrade Estelle Barbier Bohdan B Khomtchouk Christopher A Rienas | 2021/1 |
Selective RNA‐targeting of mTORC1 and 2 to ameliorate Alzheimer’s Disease pathogenesis | Alzheimer's & Dementia | Jack Stahl Aswathy Joji Olga Khorkova Claude‐Henry Volmar Claes Wahlestedt | 2023/12 |
Nucleic acid-based therapeutics for the treatment of central nervous system disorders | Robyn McCartan Olga Khorkova Claude-Henry Volmar Claes Wahlestedt | 2023/8/16 | |
Transcriptomics for clinical and experimental biology research: hang on a seq | Tanner Stokes Haoning Howard Cen Philipp Kapranov Iain J Gallagher Andrew A Pitsillides | 2023/6 | |
A new strategy for Alzheimer’s disease: low‐dose combination of radiotherapy and pharmacological epigenetic perturbation | Alzheimer's & Dementia | Claude‐Henry Volmar Natalie R Ricciardi Farzaneh Modarresi Ines Lohse Nadja S Andrade | 2023/12 |
Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer’s Disease Models | Molecular neurobiology | Natalie R Ricciardi Farzaneh Modarresi Ines Lohse Nadja S Andrade Ian R Newman | 2023/8 |
Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis | Nature communications | Josepmaria Argemi Maria U Latasa Stephen R Atkinson Ilya O Blokhin Veronica Massey | 2023/2/10 |
Microglia contribute to methamphetamine reinforcement and reflect persistent transcriptional and morphological adaptations to the drug | bioRxiv | Samara J Vilca Alexander V Margetts Isabella Fleites Claes Wahlestedt Luis M Tuesta | 2023/10/23 |
Dopamine Transporter Knockout Rats Display Epigenetic Alterations in Response to Cocaine Exposure | Biomolecules | Samara Vilca Claes Wahlestedt Sari Izenwasser Raul R Gainetdinov Marta Pardo | 2023/7/12 |
Pro-and Anti-inflammatory Biomarkers as Predictors of Response to Valproate in Patients with Comorbid Alcohol Use and Bipolar Disorder-Preliminary Findings | Ilya Blokhin Lisa Harlow Eleonore Beurel Feng Miao Dana Ascherman | 2023 | |
Long non-coding RNA-targeting therapeutics: discovery and development update | Olga Khorkova Jack Stahl Aswathy Joji Claude-Henry Volmar Zane Zeier | 2023/9/2 | |
Amplifying gene expression with RNA-targeted therapeutics | Olga Khorkova Jack Stahl Aswathy Joji Claude-Henry Volmar Claes Wahlestedt | 2023/7 | |
Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease | Roshni C Lalwani Claude-Henry Volmar Claes Wahlestedt Keith A Webster Lina A Shehadeh | 2023/12/6 | |
Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD Mouse | Biomolecules | Jessica Dennison Armando Mendez Angela Szeto Ines Lohse Claes Wahlestedt | 2023/8/29 |
Development of formulated resveratrol (micellar resveratrol) as a small molecule treatment for MPS I | Molecular Genetics and Metabolism | Shaun Brothers Claude-Henry Volmar Nancy T Chee Claes Wahlestedt Marshall Hayward | 2022/2/1 |
Non-coding RNAs in hepatocellular carcinoma | Mascha Korsch Alexander Margetts Claes Wahlestedt Ines Lohse | 2022/9/2 | |
Functional drug screening of small molecule inhibitors of epigenetic modifiers in refractory AML patients | Cancers | Jessica L Dennison Hassan Al-Ali Claude-Henry Volmar Shaun Brothers Justin Watts | 2022/8/24 |
A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease | Elife | James A Timmons Andrew Anighoro Robert J Brogan Jack Stahl Claes Wahlestedt | 2022/1/17 |
